메뉴 건너뛰기




Volumn 96, Issue , 2015, Pages 217-225

Diels-Alder hydrogels with enhanced stability: First step toward controlled release of bevacizumab

Author keywords

Bevacizumab; Controlled release; Degradation; Diels Alder reaction; Hydrogel; Poly(ethylene glycol)

Indexed keywords

AMINOCAPROIC ACID; BEVACIZUMAB; LYSINE; MALEIMIDE; MONOMER; ANGIOGENESIS INHIBITOR; DELAYED RELEASE FORMULATION; FURAN DERIVATIVE; HYDROGEL; MACROGOL DERIVATIVE; MALEIMIDE DERIVATIVE; VASCULOTROPIN;

EID: 84939502781     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2015.07.024     Document Type: Article
Times cited : (38)

References (35)
  • 1
    • 52949129894 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration
    • M.S. Ip, I.U. Scott, G.C. Brown, M.M. Brown, A.C. Ho, S.S. Huang, and et al. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration Ophthalmology 115 2008 1837 1846 10.1016/j.ophtha.2008.08.012
    • (2008) Ophthalmology , vol.115 , pp. 1837-1846
    • Ip, M.S.1    Scott, I.U.2    Brown, G.C.3    Brown, M.M.4    Ho, A.C.5    Huang, S.S.6
  • 2
    • 84867096307 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema
    • A.C. Ho, I.U. Scott, S.J. Kim, G.C. Brown, M.M. Brown, M.S. Ip, and et al. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema Ophthalmology 119 2012 2179 2188 10.1016/j.ophtha.2012.07.058
    • (2012) Ophthalmology , vol.119 , pp. 2179-2188
    • Ho, A.C.1    Scott, I.U.2    Kim, S.J.3    Brown, G.C.4    Brown, M.M.5    Ip, M.S.6
  • 3
    • 84908384270 scopus 로고    scopus 로고
    • Controlled release of therapeutic antibody formats
    • D. Schweizer, T. Serno, and A.M. Goepferich Controlled release of therapeutic antibody formats Eur. J. Pharm. Biopharm. 88 2014 291 309 10.1016/j.ejpb.2014.08.001
    • (2014) Eur. J. Pharm. Biopharm. , vol.88 , pp. 291-309
    • Schweizer, D.1    Serno, T.2    Goepferich, A.M.3
  • 4
    • 77951295054 scopus 로고    scopus 로고
    • Complications of intravitreal injections
    • K.M. Sampat, and S.J. Garg Complications of intravitreal injections Cur. Opin. Ophthalmol. 21 2010 178 183 10.1097/ICU.0b013e328338679a
    • (2010) Cur. Opin. Ophthalmol. , vol.21 , pp. 178-183
    • Sampat, K.M.1    Garg, S.J.2
  • 5
    • 60149111910 scopus 로고    scopus 로고
    • PEG hydrogels for the controlled release of biomolecules in regenerative medicine
    • C.-C. Lin, and K.S. Anseth PEG hydrogels for the controlled release of biomolecules in regenerative medicine Pharm. Res. 26 2009 631 643 10.1007/s11095-008-9801-2
    • (2009) Pharm. Res. , vol.26 , pp. 631-643
    • Lin, C.-C.1    Anseth, K.S.2
  • 6
    • 84861076436 scopus 로고    scopus 로고
    • Hydrogels for protein delivery
    • T. Vermonden, R. Censi, and W.E. Hennink Hydrogels for protein delivery Chem. Rev. 112 2012 2853 2888 10.1021/cr200157d
    • (2012) Chem. Rev. , vol.112 , pp. 2853-2888
    • Vermonden, T.1    Censi, R.2    Hennink, W.E.3
  • 7
    • 84883311793 scopus 로고    scopus 로고
    • Investigation of the Diels-Alder reaction as a cross-linking mechanism for degradable poly(ethylene glycol) based hydrogels
    • S. Kirchhof, F.P. Brandl, N. Hammer, and A.M. Goepferich Investigation of the Diels-Alder reaction as a cross-linking mechanism for degradable poly(ethylene glycol) based hydrogels J. Mater. Chem. B 1 2013 4855 4864 10.1039/c3tb20831a
    • (2013) J. Mater. Chem. B , vol.1 , pp. 4855-4864
    • Kirchhof, S.1    Brandl, F.P.2    Hammer, N.3    Goepferich, A.M.4
  • 9
    • 63049131601 scopus 로고    scopus 로고
    • Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye
    • J.J. Kang, and W.F. Derwent Mieler Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye Trans. Am. Ophthalmol. Soc. 106 2008 206 214
    • (2008) Trans. Am. Ophthalmol. Soc. , vol.106 , pp. 206-214
    • Kang, J.J.1    Derwent Mieler, W.F.2
  • 10
    • 79952107113 scopus 로고    scopus 로고
    • The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function
    • S.B. Turturro, M.J. Guthrie, A.A. Appel, P.W. Drapala, E.M. Brey, V.H. Pérez-Luna, and et al. The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function Biomaterials 32 2011 3620 3626 10.1016/j.biomaterials.2011.01.058
    • (2011) Biomaterials , vol.32 , pp. 3620-3626
    • Turturro, S.B.1    Guthrie, M.J.2    Appel, A.A.3    Drapala, P.W.4    Brey, E.M.5    Pérez-Luna, V.H.6
  • 12
    • 37049107998 scopus 로고
    • Hydrolysis of some N-alkylmaleimides
    • S. Matsui, and H. Aida Hydrolysis of some N-alkylmaleimides J. Chem. Soc., Perkin Trans. 2 1978 1277 1280 10.1039/P29780001277
    • (1978) J. Chem. Soc., Perkin Trans. , vol.2 , pp. 1277-1280
    • Matsui, S.1    Aida, H.2
  • 13
    • 79955132179 scopus 로고    scopus 로고
    • Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis
    • C.P. Ryan, M.E.B. Smith, F.F. Schumacher, D. Grohmann, D. Papaioannou, G. Waksman, and et al. Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis Chem. Commun. 47 2011 5452 10.1039/c1cc11114k
    • (2011) Chem. Commun. , vol.47 , pp. 5452
    • Ryan, C.P.1    Smith, M.E.B.2    Schumacher, F.F.3    Grohmann, D.4    Papaioannou, D.5    Waksman, G.6
  • 15
    • 84921407368 scopus 로고    scopus 로고
    • Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates
    • R.P. Lyon, J.R. Setter, T.D. Bovee, S.O. Doronina, J.H. Hunter, M.E. Anderson, and et al. Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates Nat. Biotechnol. 32 2014 1059 1062 10.1038/nbt.2968
    • (2014) Nat. Biotechnol. , vol.32 , pp. 1059-1062
    • Lyon, R.P.1    Setter, J.R.2    Bovee, T.D.3    Doronina, S.O.4    Hunter, J.H.5    Anderson, M.E.6
  • 16
    • 81255143206 scopus 로고    scopus 로고
    • Regenerative biomaterials that "click": simple, aqueous-based protocols for hydrogel synthesis, surface immobilization, and 3D patterning
    • C.M. Nimmo, and M.S. Shoichet Regenerative biomaterials that "click": simple, aqueous-based protocols for hydrogel synthesis, surface immobilization, and 3D patterning Bioconj. Chem. 22 2011 2199 2209 10.1021/bc200281k
    • (2011) Bioconj. Chem. , vol.22 , pp. 2199-2209
    • Nimmo, C.M.1    Shoichet, M.S.2
  • 17
    • 79955412522 scopus 로고    scopus 로고
    • Diels-Alder click cross-linked hyaluronic acid hydrogels for tissue engineering
    • C.M. Nimmo, S.C. Owen, and M.S. Shoichet Diels-Alder click cross-linked hyaluronic acid hydrogels for tissue engineering Biomacromolecules 12 2011 824 830 10.1021/bm101446k
    • (2011) Biomacromolecules , vol.12 , pp. 824-830
    • Nimmo, C.M.1    Owen, S.C.2    Shoichet, M.S.3
  • 18
    • 84880849182 scopus 로고    scopus 로고
    • Kinetic study of Diels-Alder reaction involving in maleimide-furan compounds and linear polyurethane
    • X. Liu, P. Du, L. Liu, Z. Zheng, X. Wang, T. Joncheray, and et al. Kinetic study of Diels-Alder reaction involving in maleimide-furan compounds and linear polyurethane Polym. Bull. 70 2013 2319 2335 10.1007/s00289-013-0954-8
    • (2013) Polym. Bull. , vol.70 , pp. 2319-2335
    • Liu, X.1    Du, P.2    Liu, L.3    Zheng, Z.4    Wang, X.5    Joncheray, T.6
  • 19
    • 0032319131 scopus 로고    scopus 로고
    • Rheological characterisation of polymer gels
    • G.M. Kavanagh, and S.B. Ross-Murphy Rheological characterisation of polymer gels Prog. Polym. Sci. 23 1998 533 562 10.1016/S0079-6700(97)00047-6
    • (1998) Prog. Polym. Sci. , vol.23 , pp. 533-562
    • Kavanagh, G.M.1    Ross-Murphy, S.B.2
  • 20
    • 79953211477 scopus 로고    scopus 로고
    • Effective electrophoretic mobilities and charges of anti-VEGF proteins determined by capillary zone electrophoresis
    • S.K. Li, M.R. Liddell, and H. Wen Effective electrophoretic mobilities and charges of anti-VEGF proteins determined by capillary zone electrophoresis J. Pharm. Biomed. Anal. 55 2011 603 607 10.1016/j.jpba.2010.12.027
    • (2011) J. Pharm. Biomed. Anal. , vol.55 , pp. 603-607
    • Li, S.K.1    Liddell, M.R.2    Wen, H.3
  • 21
    • 84924086510 scopus 로고    scopus 로고
    • Protein compatibility of selected cross-linking reactions for hydrogels
    • N. Hammer, F.P. Brandl, S. Kirchhof, V. Messmann, and A.M. Goepferich Protein compatibility of selected cross-linking reactions for hydrogels Macromol. Biosci. 15 2015 405 413 10.1002/mabi.201400379
    • (2015) Macromol. Biosci. , vol.15 , pp. 405-413
    • Hammer, N.1    Brandl, F.P.2    Kirchhof, S.3    Messmann, V.4    Goepferich, A.M.5
  • 22
    • 0037124466 scopus 로고    scopus 로고
    • PEGylated antibodies and antibody fragments for improved therapy: a review
    • A.P. Chapman PEGylated antibodies and antibody fragments for improved therapy: a review Adv. Drug Deliv. Rev. 54 2002 531 545 10.1016/S0169-409X(02)00026-1
    • (2002) Adv. Drug Deliv. Rev. , vol.54 , pp. 531-545
    • Chapman, A.P.1
  • 23
    • 66349109049 scopus 로고    scopus 로고
    • Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration
    • M. Abrishami, S. Zarei-Ghanavati, D. Soroush, M. Rouhbakhsh, M.R. Jaafari, and B. Malaekeh-Nikouei Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration Retina 29 2009 699 703 10.1097/IAE.0b013e3181a2f42a
    • (2009) Retina , vol.29 , pp. 699-703
    • Abrishami, M.1    Zarei-Ghanavati, S.2    Soroush, D.3    Rouhbakhsh, M.4    Jaafari, M.R.5    Malaekeh-Nikouei, B.6
  • 24
    • 78650141563 scopus 로고    scopus 로고
    • Sustained release of a monoclonal antibody from electrochemically prepared mesoporous silicon oxide
    • J.S. Andrew, E.J. Anglin, E.C. Wu, M.Y. Chen, L. Cheng, W.R. Freeman, and et al. Sustained release of a monoclonal antibody from electrochemically prepared mesoporous silicon oxide Adv. Funct. Mater. 20 2010 4168 4174 10.1002/adfm.201000907
    • (2010) Adv. Funct. Mater. , vol.20 , pp. 4168-4174
    • Andrew, J.S.1    Anglin, E.J.2    Wu, E.C.3    Chen, M.Y.4    Cheng, L.5    Freeman, W.R.6
  • 25
    • 84863798254 scopus 로고    scopus 로고
    • Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration
    • F. Li, B. Hurley, Y. Liu, B. Leonard, and M. Griffith Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration Open Ophthalmol. J. 6 2012 54 58 10.2174/1874364101206010054
    • (2012) Open Ophthalmol. J. , vol.6 , pp. 54-58
    • Li, F.1    Hurley, B.2    Liu, Y.3    Leonard, B.4    Griffith, M.5
  • 26
    • 79958784449 scopus 로고    scopus 로고
    • Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model
    • C.K. Pan, C. Durairaj, U.B. Kompella, O. Agwu, S.C.N. Oliver, H. Quiroz-Mercado, and et al. Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model J. Ocul. Pharmacol. Ther. 27 2011 219 224 10.1089/jop.2010.0158
    • (2011) J. Ocul. Pharmacol. Ther. , vol.27 , pp. 219-224
    • Pan, C.K.1    Durairaj, C.2    Kompella, U.B.3    Agwu, O.4    Oliver, S.C.N.5    Quiroz-Mercado, H.6
  • 27
    • 84881329600 scopus 로고    scopus 로고
    • Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab
    • P. Tyagi, M. Barros, J.W. Stansbury, and U.B. Kompella Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab Mol. Pharm. 10 2013 2858 2867 10.1021/mp300716t
    • (2013) Mol. Pharm. , vol.10 , pp. 2858-2867
    • Tyagi, P.1    Barros, M.2    Stansbury, J.W.3    Kompella, U.B.4
  • 28
    • 84862907578 scopus 로고    scopus 로고
    • Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel
    • C.-H. Wang, Y.-S. Hwang, P.-R. Chiang, C.-R. Shen, W.-H. Hong, and G.-H. Hsiue Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel Biomacromolecules 13 2012 40 48 10.1021/bm2009558
    • (2012) Biomacromolecules , vol.13 , pp. 40-48
    • Wang, C.-H.1    Hwang, Y.-S.2    Chiang, P.-R.3    Shen, C.-R.4    Hong, W.-H.5    Hsiue, G.-H.6
  • 29
    • 84879745724 scopus 로고    scopus 로고
    • Sustained release of Avastin® from polysaccharides cross-linked hydrogels for ocular drug delivery
    • X. Xu, Y. Weng, L. Xu, and H. Chen Sustained release of Avastin® from polysaccharides cross-linked hydrogels for ocular drug delivery Int. J. Biol. Macromol. 60 2013 272 276 10.1016/j.ijbiomac.2013.05.034
    • (2013) Int. J. Biol. Macromol. , vol.60 , pp. 272-276
    • Xu, X.1    Weng, Y.2    Xu, L.3    Chen, H.4
  • 30
    • 84902296594 scopus 로고    scopus 로고
    • In situ covalently cross-linked PEG hydrogel for ocular drug delivery applications
    • J. Yu, X. Xu, F. Yao, Z. Luo, L. Jin, B. Xie, and et al. In situ covalently cross-linked PEG hydrogel for ocular drug delivery applications Int. J. Pharm. 470 2014 151 157 10.1016/j.ijpharm.2014.04.053
    • (2014) Int. J. Pharm. , vol.470 , pp. 151-157
    • Yu, J.1    Xu, X.2    Yao, F.3    Luo, Z.4    Jin, L.5    Xie, B.6
  • 31
    • 84920911962 scopus 로고    scopus 로고
    • Formulation of in situ chemically cross-linked hydrogel depots for protein release: from the blob model perspective
    • Y. Yu, and Y. Chau Formulation of in situ chemically cross-linked hydrogel depots for protein release: from the blob model perspective Biomacromolecules 16 2015 56 65 10.1021/bm501063n
    • (2015) Biomacromolecules , vol.16 , pp. 56-65
    • Yu, Y.1    Chau, Y.2
  • 32
    • 84939493345 scopus 로고    scopus 로고
    • Injectable chemically crosslinked hydrogel for the controlled release of bevacizumab in vitreous: a 6-month in vivo study
    • Y. Yu, L.C.M. Lau, A.C.-Y. Lo, and Y. Chau Injectable chemically crosslinked hydrogel for the controlled release of bevacizumab in vitreous: a 6-month in vivo study Trans. Vis. Sci. Technol. 4 2015 5 10.1167/tvst.4.2.5
    • (2015) Trans. Vis. Sci. Technol. , vol.4 , pp. 5
    • Yu, Y.1    Lau, L.C.M.2    Lo, A.C.-Y.3    Chau, Y.4
  • 33
    • 77953359005 scopus 로고    scopus 로고
    • Mechanisms of retinal ganglion cell injury and defense in glaucoma
    • J. Qu, D. Wang, and C.L. Grosskreutz Mechanisms of retinal ganglion cell injury and defense in glaucoma Exp. Eye Res. 91 2010 48 53 10.1016/j.exer.2010.04.002
    • (2010) Exp. Eye Res. , vol.91 , pp. 48-53
    • Qu, J.1    Wang, D.2    Grosskreutz, C.L.3
  • 34
    • 84868623614 scopus 로고    scopus 로고
    • Turning a blind eye to anti-VEGF toxicities
    • S.E. Quaggin Turning a blind eye to anti-VEGF toxicities J. Clin. Invest. 122 2012 3849 3851 10.1172/JCI65509
    • (2012) J. Clin. Invest. , vol.122 , pp. 3849-3851
    • Quaggin, S.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.